Advertisement

Annals of Surgical Oncology

, Volume 21, Issue 7, pp 2429–2435 | Cite as

HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma

  • Won Sohn
  • Yong-Han Paik
  • Jong Man Kim
  • Choon Hyuk Kwon
  • Jae Won Joh
  • Ju Yeon Cho
  • Geum-Youn Gwak
  • Moon Seok Choi
  • Joon Hyeok Lee
  • Kwang Cheol Koh
  • Seung Woon Paik
  • Byung Chul Yoo
Hepatobiliary Tumors

Abstract

Background

Recent studies have shown that high hepatitis B virus (HBV) load is associated with increased risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). The aim of our study was to investigate the predictive role of HBV DNA and hepatitis B surface antigen (HBsAg) levels in early and late recurrence of HCC after curative resection in patients with HBV-related HCC.

Methods

From January 2008 to December 2010, a total of 248 patients underwent curative resection for HBV-related early-stage HCC (solitary tumor; < 5 cm in diameter or multinodular tumor; number of tumors ≤3 and diameter < 3 cm). We analyzed the predictive factors including HBV DNA and HBsAg levels for early recurrence (within 2 years) and late recurrence (after 2 years) of HCC after curative resection.

Results

The median follow-up duration was 33.3 months. Cumulative recurrence rates after resection at 1, 3, and 5 years were 16.6, 34.0, and 46.7 %, respectively. The multivariate analysis showed that risk factors for early recurrence were the presence of microvascular invasion (hazard ratio [HR] 3.86; p < 0.001), preoperative HBV DNA levels ≥ 20,000 IU/mL (HR 2.77; p < 0.001), and des-γ-carboxy prothrombin level ≥ 40 mAU/mL (HR 1.76; p = 0.045). Although, the risk factors for late recurrence by multivariate analysis were preoperative HBsAg levels ≥ 4,000 IU/mL (HR 2.80; p = 0.023) and age at resection ≥ 50 years (HR 3.22; p = 0.032).

Conclusion

The HBV DNA levels were associated with early recurrence, whereas HBsAg levels were associated with late recurrence after curative resection in HBV-related HCC.

Keywords

Early Recurrence Late Recurrence Microvascular Invasion HBsAg Level Serum HBsAg Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Disclosure

There are no competing interests.

Supplementary material

10434_2014_3621_MOESM1_ESM.docx (133 kb)
Supplementary material 1 (DOCX 133 kb)

References

  1. 1.
    McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. 2005;25 Suppl 1:3–8.PubMedCrossRefGoogle Scholar
  2. 2.
    McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology.2009;49 5 Suppl:S45–55.PubMedCrossRefGoogle Scholar
  3. 3.
    Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA.2006;295:65–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Bruix J, Sherman M. Practice Guidelines Committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–36.PubMedCrossRefGoogle Scholar
  5. 5.
    European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer collaborators. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.Google Scholar
  6. 6.
    Lim KC, Chow PK, Allen JC, Siddiqui FJ, Chan ES, Tan SB. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria. The Br J Surg. 2012;99:1622–9.CrossRefGoogle Scholar
  7. 7.
    Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10–24.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol. 2008;103:1663–73.PubMedCrossRefGoogle Scholar
  9. 9.
    Qu LS, Jin F, Huang XW, Shen XZ. High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection. J Gastrointest Surg2010;14:1111–20.PubMedCrossRefGoogle Scholar
  10. 10.
    Liaw YF. Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review. Hepatology. 2011;54:E1–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Janssen HL, Sonneveld MJ, Brunetto MR. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B? Gut. 2012;61:641–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Tseng TC, Liu CJ, Yang HC, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 2012;142:1140–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer. 1954;7:462–503.PubMedCrossRefGoogle Scholar
  14. 14.
    Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting.Am J Surg Pathol. 1995;19:1409–17.PubMedCrossRefGoogle Scholar
  15. 15.
    Pons F, Varela M, Llovet JM. Staging systems in hepatocellular carcinoma. HPB (Oxford). 2005;7:35–41.PubMedCentralPubMedCrossRefGoogle Scholar
  16. 16.
    Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Wu JC, Huang YH, Chau GY, et al. Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma. J Hepatol. 2009;51:890–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Yang T, Lu JH, Zhai J, et al. High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study. Eur J Surg Oncol.2012;38:683–91.PubMedCrossRefGoogle Scholar
  19. 19.
    Kim BK, Park JY, Kim do Y, et al. Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int.2008;28:393–401.PubMedCrossRefGoogle Scholar
  20. 20.
    An HJ, Jang JW, Bae SH, et al. Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2010;25:1876–82.PubMedCrossRefGoogle Scholar
  21. 21.
    Chan HL, Thompson A, Martinot-Peignoux M, et al. Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. J Hepatol. 2011;55:1121–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J, Lai CL. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol. 2006;45:553–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Wang M, Qiu N, Lu S, et al. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naive patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma. J Med Virol. 2013;85:219–27.PubMedCrossRefGoogle Scholar
  24. 24.
    Tseng TC, Liu CJ, Yang HC, et al. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Hepatology. 2013;57:441–50.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2014

Authors and Affiliations

  • Won Sohn
    • 1
  • Yong-Han Paik
    • 1
  • Jong Man Kim
    • 2
  • Choon Hyuk Kwon
    • 2
  • Jae Won Joh
    • 2
  • Ju Yeon Cho
    • 1
  • Geum-Youn Gwak
    • 1
  • Moon Seok Choi
    • 1
  • Joon Hyeok Lee
    • 1
  • Kwang Cheol Koh
    • 1
  • Seung Woon Paik
    • 1
  • Byung Chul Yoo
    • 1
  1. 1.Division of Gastroenterology, Department of MedicineSamsung Medical Center, Sungkyunkwan University School of MedicineSeoulKorea
  2. 2.Department of Surgery, Samsung Medical CenterSungkyunkwan University School of MedicineSeoulKorea

Personalised recommendations